Last reviewed · How we verify
IDEC-159 90Y
At a glance
| Generic name | IDEC-159 90Y |
|---|---|
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |